Statistics
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
| Views | |
|---|---|
| A ... | 1409 |
Total Visits Per Month
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| A ... | 24 | 2 | 4 | 15 | 18 | 24 | 6 |
File Visits
| Views | |
|---|---|
| 29FL5e9GFDkgQ.pdf | 461 |